1. This report on the I-SPY 2 Clinical Trial was provided to the Foundation for NIH courtesy of NBC News 4 (WRC-TV) in Washington DC.

    The highly anticipated clinical trial is a groundbreaking public-private collaboration of the Foundation for NIH's The Biomarkers Consortium, combining personalized medicine with a novel trial design to develop potentially life saving new breast cancer drugs.

    # vimeo.com/10264209 Uploaded 418 Plays / / 0 Comments Watch in Couch Mode
  2. On March 17, 2010, Susan Desmond-Hellmann, MD, MPH, Chancellor of the University of California, San Francisco, spoke at the I-SPY 2 Press Conference, held at the National Press Club.

    The highly anticipated clinical trial is a groundbreaking public-private collaboration of the Foundation for NIH's The Biomarkers Consortium, combining personalized medicine with a novel trial design to develop potentially life saving new breast cancer drugs.

    # vimeo.com/10263396 Uploaded 57 Plays / / 0 Comments Watch in Couch Mode

I-SPY 2 Breast Cancer Trial

Foundation for NIH Plus

I-SPY 2 is a clinical trial for women with newly diagnosed locally advanced breast cancer. The trial employs a groundbreaking model that uses genetic or biological markers (“biomarkers”) from individual patients’ tumors to screen promising new treatments,


+ More

I-SPY 2 is a clinical trial for women with newly diagnosed locally advanced breast cancer. The trial employs a groundbreaking model that uses genetic or biological markers (“biomarkers”) from individual patients’ tumors to screen promising new treatments, identifying which treatments are most effective in specific types of patients. Learn more at ispy2.org.

Browse This Channel

Shout Box

Channels are a simple, beautiful way to showcase and watch videos. Browse more Channels. Channels